(Q40636792)

22 September 2017

1 reference

title

Current concepts in primary sclerosing cholangitis (English)

1 reference

primary sclerosing cholangitis

22 September 2017

ascending cholangitis

0 references

1 reference

R H Wiesner

1

1 reference

PubMed ID

7934194

22 September 2017

language of work or name

English

0 references

publication date

1 October 1994

1 reference

22 September 2017

1 reference

22 September 2017

69

1 reference

22 September 2017

10

1 reference

22 September 2017

969-982

1 reference

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Natural history and prognostic variables in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Primary sclerosing cholangitis: a progressive disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Sclerosing Cholangitis: Its Increasing Frequency of Recognition and Association with Inflammatory Bowel Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Cholangiocarcinoma complicating primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Relationship of inflammatory bowel disease and primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Portal bacteraemia in cases of ulcerative colitis submitted to colectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Portal vein bile acids in patients with severe inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Primary sclerosing cholangitis. A study of forty-two cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Bile acids in liver disease associated with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Hepatobiliary disease that precedes ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Sclerosing cholangitis in ulcerative colitis. A follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Obliterative cholangitis due to cytomegalovirus: A possible precursor of paucity of intrahepatic bile ducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

A survey of cytomegalovirus (CMV) DNA in primary sclerosing cholangitis (PSC) liver tissues using a sensitive polymerase chain reaction (PCR) based assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Chronic obstructive jaundice induced by Reovirus type 3 in weanling mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Biliary Atresia and Reovirus Type 3 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Association of primary sclerosing cholangitis with HLA-B8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Association of primary sclerosing cholangitis with HLA-DRw52a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility to and protection from primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Family incidence of primary sclerosing cholangitis associated with immunologic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Lymphocyte subsets in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Primary sclerosing cholangitis: a long-term follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Primary sclerosing cholangitis: refinement and validation of survival models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic and bacteriological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Azathioprine in primary sclerosing cholangitif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

The pruritus of cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Pathogenesis of steatorrhea in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Primary sclerosing cholangitis and celiac disease. A novel association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Transjugular intrahepatic portal-systemic shunts: the state of the art.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Endoscopic and radiologic approaches to therapy in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Gallbladder disease in patients with primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Sclerosing cholangitis: palliation with percutaneous cholangioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Resection of Hepatic Duct Bifurcation and Transhepatic Stenting for Sclerosing Cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Orthotopic liver transplantation for primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Prolonged relief of intractable pruritus in primary sclerosing cholangitis by plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961822-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)61822-9

1 reference

22 September 2017

1 reference

PubMed ID

7934194